Michael Gunnar Knell Charles River Laboratories International, Inc. (CRL) insider trading activity

Michael Gunnar Knell is CSVP&Chief Accounting Officer of CHARLES RIVER LABORATORIES INTERNATIONAL, INC.. Currently has a direct ownership of 8,326 shares of CRL, which is worth approximately $1.56 Million. The most recent transaction as insider was on May 31, 2024, when has been sold 648 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.33K

0% 3M change

16.24% 12M change

Total Value Held $1.56 Million

Michael Gunnar Knell Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 31 2024	BUY Grant, award, or other acquisition	-	648 Added 7.22%	8,326 Common Stock
May 29 2024	SELL Payment of exercise price or tax liability	$7,722 $214.51 p/Share	36 Reduced 0.47%	7,678 Common Stock
May 28 2024	SELL Payment of exercise price or tax liability	$5,213 $217.21 p/Share	24 Reduced 0.31%	7,714 Common Stock
May 27 2024	SELL Payment of exercise price or tax liability	$8,036 $217.21 p/Share	37 Reduced 0.48%	7,738 Common Stock
May 26 2024	SELL Payment of exercise price or tax liability	$10,860 $217.21 p/Share	50 Reduced 0.64%	7,775 Common Stock
Mar 08 2024	SELL Open market or private sale	$216,156 $267.52 p/Share	808 Reduced 10.32%	7,024 Common Stock
Mar 04 2024	SELL Open market or private sale	$718,080 $261.12 p/Share	2,750 Reduced 25.99%	7,832 Common Stock
Jan 29 2024	SELL Payment of exercise price or tax liability	$71,811 $220.28 p/Share	326 Reduced 2.99%	10,582 Common Stock
Jan 29 2024	BUY Grant, award, or other acquisition	-	968 Added 8.15%	10,908 Common Stock
Aug 10 2023	SELL Open market or private sale	$318,530 $216.54 p/Share	1,471 Reduced 12.89%	9,940 Common Stock
Aug 10 2023	BUY Exercise of conversion of derivative security	$212,809 $144.67 p/Share	1,471 Added 11.42%	11,411 Common Stock
Jun 01 2023	BUY Grant, award, or other acquisition	-	1,528 Added 13.32%	9,940 Common Stock
May 29 2023	SELL Payment of exercise price or tax liability	$6,988 $194.12 p/Share	36 Reduced 0.43%	8,412 Common Stock
May 28 2023	SELL Payment of exercise price or tax liability	$4,658 $194.12 p/Share	24 Reduced 0.28%	8,448 Common Stock
May 27 2023	SELL Payment of exercise price or tax liability	$6,988 $194.12 p/Share	36 Reduced 0.42%	8,472 Common Stock
May 26 2023	BUY Grant, award, or other acquisition	-	670 Added 7.3%	8,508 Common Stock
Feb 22 2023	SELL Payment of exercise price or tax liability	$12,423 $243.6 p/Share	51 Reduced 0.65%	7,838 Common Stock
Jan 27 2023	SELL Payment of exercise price or tax liability	$157,567 $244.29 p/Share	645 Reduced 7.56%	7,889 Common Stock
Jan 27 2023	BUY Grant, award, or other acquisition	-	2,096 Added 19.72%	8,534 Common Stock
Nov 16 2022	SELL Open market or private sale	$212,544 $248.59 p/Share	855 Reduced 11.72%	6,438 Common Stock
Nov 16 2022	BUY Exercise of conversion of derivative security	$93,485 $109.34 p/Share	855 Added 10.49%	7,293 Common Stock
May 29 2022	SELL Payment of exercise price or tax liability	$13,198 $244.41 p/Share	54 Reduced 0.83%	6,438 Common Stock
May 28 2022	SELL Payment of exercise price or tax liability	$9,043 $244.41 p/Share	37 Reduced 0.57%	6,492 Common Stock
May 27 2022	BUY Grant, award, or other acquisition	-	491 Added 6.99%	6,529 Common Stock
Feb 23 2022	SELL Payment of exercise price or tax liability	$16,216 $289.58 p/Share	56 Reduced 0.92%	6,038 Common Stock

MGK

Michael Gunnar Knell

CSVP&Chief Accounting Officer

Wilmington, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRL shares.

Notify only if

Value

Insider Trading

Get notified when an Charles River Laboratories International, Inc. insider buys or sells CRL shares.

Notify only if

Operation

Value

Type

News

Receive news related to CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Track Activities on CRL

Account